Five researchers receive shared $9 million grant from Aligning Science Across Parkinson’s initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A multi-institutional team of scientists has received a grant from the Aligning Science Across Parkinson’s (ASAP) initiative to use stem cells to study how risk factors accumulate and interact to drive Parkinson’s disease (PD).

The team is led by Lorenz Studer, of Memorial Sloan Kettering Cancer Center, and includes including Gist Croft, of The NYSCF Research Institute; Vikram Khurana, of Brigham and Women’s Hospital, and a NYSCF – Robertson stem cell investigator; Jian Peng, of (University of Illinois at Urbana-Champaign; and Joseph Powell, of Garvan Institute of Medical Research.

The team will receive $9 million over three years to take a comprehensive look at the interplay between genetics, aging, and different brain cell types underlying individual risk for PD in a project entitled, “Defining the cellular and molecular determinants of variable genetic penetrance in Parkinson’s disease.”

Table of Contents

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
In January, FDA released a draft guidance entitled “Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval.” This release came roughly 20 months after the Oncologic Drugs Advisory Committee (ODAC) voted unanimously that minimal residual disease (MRD) negativity, in combination with complete response (CR), is an acceptable primary endpoint to support accelerated approval for multiple myeloma (MM) therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login